Jacqueline Brandwynne
Chief Executive Officer at Brandwynne Corp.
Profile
Ms. Jacqueline Brandwynne is President & Chief Executive Officer at Brandwynne Corp.
and an Advisor at Proteus Venture Partners LLC (Venture Capital).
She is on the Board of Directors at Cedars Sinai Health System and California Institute of the Arts.
Ms. Brandwynne was previously employed as Independent Director by ImmunoCellular Therapeutics Ltd.
She also served on the board at MicroVision, Inc. and Pacific Union Bank.
Jacqueline Brandwynne active positions
| Companies | Position | Start |
|---|---|---|
| Brandwynne Corp. | Chief Executive Officer | 2011-02-21 |
| California Institute of the Arts | Director/Board Member | 2011-02-21 |
Former positions of Jacqueline Brandwynne
| Companies | Position | End |
|---|---|---|
| Pacific Union Bank (California) | Director/Board Member | 2013-01-14 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2012-09-23 |
| MICROVISION, INC. | Director/Board Member | 2006-02-27 |
Cedars Sinai Health System
 Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Director/Board Member | - |
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Consultant / Advisor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MICROVISION, INC. | Electronic Technology |
| Private companies | 5 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
| Pacific Union Bank (California) | Finance |
Cedars Sinai Health System
Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
| Brandwynne Corp. |
- Stock Market
- Insiders
- Jacqueline Brandwynne